Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05887388 · ClinicalTrials.gov registry record · NA
Adapting Connect-Home Transitional Care for the Unique Needs of Persons With Alzheimer's Disease and Other Dementias and Their Caregivers
A NA study of Pathologic Processes, sponsored by University of North Carolina, Chapel Hill.
- Completed
- Registry status
- NA
- Development phase
- 38
- Enrollment target
- 1
- Study location
NCT05887388 is a NA study of Pathologic Processes that has completed, run by University of North Carolina, Chapel Hill. The registered enrollment target is 38 participants, below the 892-participant average among 13 other Pathologic Processes trials with a reported enrollment target (96% lower). The trial reports 1 study location across 1 state.
The verdict
NCT05887388, a NA study of Pathologic Processes, has completed, sponsored by University of North Carolina, Chapel Hill.
- COMPLETED
- Registry status
- NA
- Development phase
- 38 participants
- Enrollment target
- 1
- Study location
Study Summary
This primary purpose of this study will be to (1) examine the feasibility and acceptability of transitional care focusing on care needs of skilled nursing facility (SNF) patients with dementia and their caregivers (primary aim). The secondary purpose will be to describe the effect of the intervention on SNF patient outcomes (preparedness for discharge, quality of life, function and acute care use) and caregiver outcomes (preparedness for the caregiving role, caregiver burden and caregiver distress).
Conditions Studied
Interventions
- BEHAVIORAL Connect-Home Plus
Study Locations (1)
North Carolina
- UNC-Chapel Hill - Chapel Hill
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 38 participants |
| Start Date | 2021-09-10 |
| Est. Completion | 2022-03-18 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05887388
The ClinicalTrials.gov registry entry for NCT05887388 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 38 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 892-participant average among 13 other Pathologic Processes trials with a reported enrollment target (96% lower). The listed sponsor is University of North Carolina, Chapel Hill, which has 1,109 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Pathologic Processes appearing as the primary indexed condition, and to 1 intervention - of which Connect-Home Plus is the first listed.
NCT05887388 reports 1 study location spanning 1 distinct geographic area - top geographies include North Carolina.
Frequently Asked Questions
What is clinical trial NCT05887388 about?
NCT05887388 is a clinical study titled "Adapting Connect-Home Transitional Care for the Unique Needs of Persons With Alzheimer's Disease and Other Dementias and Their Caregivers". This primary purpose of this study will be to (1) examine the feasibility and acceptability of transitional care focusing on care needs of skilled nursing facility (SNF) patients with dementia and their caregivers (primary aim). The secondary purpose will be to describe the effect of the interventio...
What is the current status of trial NCT05887388?
This trial is currently completed. It is a NA study. The enrollment target is 38 participants. The study started on 2021-09-10. Estimated completion is 2022-03-18.
What conditions does trial NCT05887388 study?
This clinical trial studies the following conditions: Pathologic Processes.
What interventions are being tested in trial NCT05887388?
The interventions under investigation include: Connect-Home Plus (BEHAVIORAL).
Who is sponsoring clinical trial NCT05887388?
This trial is sponsored by University of North Carolina, Chapel Hill, which has 1,109 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05887388 being conducted?
This trial has 1 study location across North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Pathologic Processes
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Clinical Trial Assessing Human Placental Membrane Products and Standard of Care Versus Standard of Care in Nonhealing DFUs and VLUs
RECRUITING · NA
-
Maximizing Lymph Node Dissection on Fresh and Fixed Lung Cancer Resection Specimens
RECRUITING · NA
-
Insertable Cardiac Monitor-Guided Early Intervention to Reduce Atrial Fibrillation Burden Following Catheter Ablation
ACTIVE NOT RECRUITING · NA
-
Strategy to Avoid Excessive Oxygen Using an Autonomous Oxygen Titration Intervention
ACTIVE NOT RECRUITING · NA
-
pRESET for Occlusive Stroke Treatment
COMPLETED · NA
-
Oral Ifetroban to Treat Diffuse Cutaneous Systemic Sclerosis (SSc) or SSc-associated Pulmonary Arterial Hypertension
ACTIVE NOT RECRUITING · Phase 2
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.